MARC Record from marc_columbia

LEADER: 07259cam a22004334a 4500
001 5034691
005 20221109211120.0
008 040504t20052005paua b 001 0 engs
010 $a 2004010615
016 7 $a101215823$2DNLM
020 $a0781741858
035 $a(OCoLC)ocm55138785
035 $a(NNC)5034691
035 $a5034691
040 $aDNLM/DLC$cDLC$dNLM$dOCLCQ$dC#P$dOrLoB-B
042 $apcc
050 00 $aRJ560$b.P4 2005
060 00 $a2004 M-554
060 10 $aWS 366$bN4381 2005
082 00 $a615.1/083$222
245 00 $aNeonatal and pediatric pharmacology :$btherapeutic principles in practice /$c[edited by] Sumner J. Yaffe, Jacob V. Aranda.
250 $a3rd ed.
260 $aPhiladelphia :$bLippincott Williams & Wilkins,$c[2005], ©2005.
300 $axxii, 938 pages :$billustrations ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
505 00 $tForeward to the second edition /$rJerold F. Lucey -- $tForeward to the third edition /$rJerold E. Lucey -- $tPreface to the second edition /$rSumner J. Yaffe and Jacob V. Aranda -- $tPreface to the third edition /$rDuane Alexander -- $g1.$tIntroduction and historical perspectives /$rSumner J. Yaffe and Jacob V. Aranda -- $g2.$tClinical pharmacokinetics in infants and children /$rEdmund V. Capparelli -- $g3.$tDrug action and therapy in the infant and child /$rRalph E. Kauffman -- $g4.$tDrug metabolism and disposition in infants and children /$rAnders Rane -- $g5.$tPharmacogenetics, pharmacogenomics, and pharmacoproteomics /$rJ. Steven Leeder -- $g6.$tCompliance with pediatric medication regimens /$rHakan Ergun and Daniel A. C. Frattarelli -- $g7.$tClinical trials involving children : history, rationale, regulatory framework, and technical considerations /$rSteven Hirschfeld -- $g8.$tEthics of drug research in pediatric populations /$rSanford N. Cohen and Bruce L. Russell -- $g9.$tTherapeutic drug monitoring /$rAlexander A. Vinks and Philip D. Walson -- $g10.$tDrug formulations /$rMilap C. Nahata -- $g11.$tDevelopmental toxicology /$rDonald R. Mattison and John F. Young -- $g12.$tPlacental transfer of drugs /$rRada Boskovic and Gideon Koren -- $g13.$tPrinciples of neonatal pharmacology /$rJeffrey L. Blumer and Michael D. Reed -- $g14.$tPerinatal origins of adult defects in drug metabolism /$rBernard H. Shapiro -- $g15.$tRenal function and excretion of drugs in the newborn /$rJohn N. van den Anker -- $g16.$tThe excretion of drugs and chemicals in human milk /$rCheston M. Berlin, Jr. -- $g17.$tDrugs for hyperbilirubinemia /$rDavid K. Stevenson, Susan R. Hintz, Ronald J. Wong and Hendrik J. Vremen -- $g18.$tDrugs and lung development /$rAlan H. Jobe -- $g19.$tPharmacologic treatment of neonatal apnea /$rJose M. Lopes and Jacob V. Aranda -- $g20.$tDrugs and perinatal brain injury /$rMaria Delivoria-Papadopoulos, Agustin Legido and Om Prakash Mishra -- $g21.$tAntiretroviral pharmacology in pregnant women and newborns /$rMark Mirochnick -- $g22.$tTherapeutic applications in pediatric intensive care /$rMary Lieh-Lai and Ashok Sarnaik -- $g23.$tDrug therapy in the pediatric emergency department /$rShannon F. Manzi and Michael W. Shannon -- $g24.$tDrug therapy in the adolescent /$rIan M. Paul and Richard L. Levine -- $g25.$tTopical medications /$rFasahat H. Hamzavi and George J. Murakawa -- $g26.$tOphthalmologic drugs in infants and children /$rJohn D. Roarty -- $g27.$tSulfonamides /$rChokechai Rongkavilit, Jacob V. Aranda, Nahed M. Abdel-Haq, Jocelyn Y. Ang and Basim I. Asmar -- $g28.$tPenicillins, beta-lactamase inhibitors, cephalopsporins and other beta-lactams /$rSumathi Nambiar and William J. Rodriguez -- $g29.$tAminoglycosides and glycopeptides /$rMatthijs de Hoog and John N. van den Anker -- $g30.$tMacrolides, chloramphenicol, and tetracyclines /$rBasim I. Asmar and Nahed M. Abdel-Haq -- $g31.$tAnthelminthic drugs in children /$rGeorge C. F. Hsieh, Vincent C. Fan and Peter J. Hotez -- $g32.$tAntituberculosis drugs /$rAlexander O. Tuazon -- $g33.$tAntifungal agents /$rWilliam J. Steinbach and John R. Perfect -- $g34.$tAntiviral drugs /$rCharles G. Prober and David W. Kimberlin -- $g35.$tAnticonvulsants /$rVictoria Tutag Lehr, Harry T. Chugani and Jacob V. Aranda -- $g36.$tPsychopharmacology in children and adolescents /$rJulio Licinio -- $g37.$tAntihistamines /$rSanaa A. Mahmoud and Sami L. Bahna -- $g38.$tAntiasthmatics /$rGlenn J. Whelan, Joseph D. Spahn and Stanley J. Szefler -- $g39.$tAntipyretics /$rJohn T. Wilson and Margaret Ann Springer -- $g40.$tCardiovascular drugs /$rEli Zalzstein and Rafael Gorodischer -- $g41.$tDiuretics /$rJean-Pierre Guignard -- $g42.$tClinical pharmacology of antineoplastic drugs /$rStacey L. Berg and David G. Poplack -- $g43.$tImmunosuppressive and immunomodulatory drugs /$rNenna R. Gupta, Darla K. Granger, Tej K. Mattoo and Scott A. Gruber -- $g44.$tAnalgesic agents /$rSinno H. P. Simons, Brian J. Anderson and Dick Tibboel -- $g45.$tLocal anesthetics for infants and children /$rSanthanam Suresh and Charles J. Cote -- $g46.$tNonsteroidal antiinflammatory drugs /$rSylvain Chemtob -- $g47.$tAntihypertensive agents /$rThomas C. Wells and Mohammad Ilyas -- $g48.$tGastrointestinal drugs /$rLaura P. James, Henry C. Farrar, Kristine Palmer and Gregory L. Kearns -- $g49.$tGlucocorticoids /$rEvangelia Charmandari, Tomoshige Kino and George P. Chrousos -- $g50.$tInsulin and diabetes mellitus /$rTania S. Burgert and William Tamborlane -- $g51.$tThyroid hormones /$rDelbert A. Fisher -- $g52.$tGrowth hormone /$rHarvey J. Guyda -- $g53.$tHematologic agents /$rAlfred A. Alvarez, Darlene A. Calhoun and Robert D. Christensen -- $g54.$tNutrient supplements /$rMary Frances Picciano, Carolyn S. Chung and Paul M. Coates -- $g55.$tChildhood vaccines /$rDavid W. Scheifele -- $g56.$tEpidemiology of adverse drug effects /$rLouis Vernacchio and Allen A. Mitchell -- $g57.$tMedication errors /$rGeorge H. Lambert, Marc G. Sturgill and Diane D. Cousins -- $g58.$tPediatric poisonings and antidotes /$rSuzanne R. White -- $g59.$tUse of herbal products in children : risks and unproven benefits /$rWayne R. Snodgrass -- $g60.$tNeonatal abstinence syndromes /$rLoretta Finnegan and Stephen R. Kandall -- $gApp. A1.$tDrug formulary for the newborn /$rMarianne Lulic-Botica, Kevin Biglin and Jacob V. Aranda -- $gApp. A2.$tPediatric drug formulary /$rShannon F. Manzi, Alana Arnold and Al Patterson.
500 $aRev. ed. of: Pediatric pharmacology. 2nd ed. c1992.
504 $aIncludes bibliographical references and index.
650 0 $aPediatric pharmacology.$0http://id.loc.gov/authorities/subjects/sh85099170
650 0 $aPrenatal pharmacology.
650 0 $aChildren$xDiseases$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh85023435
650 0 $aNewborn infants$xEffect of drugs on.$0http://id.loc.gov/authorities/subjects/sh85066055
650 12 $aDrug Therapy$xChild.
650 12 $aDrug Therapy$xInfant.
650 22 $aPharmaceutical Preparations$xadministration & dosage.$0https://id.nlm.nih.gov/mesh/D004364Q000008
700 1 $aYaffe, Sumner J.,$d1923-2011.$0http://id.loc.gov/authorities/names/n79128058
700 1 $aAranda, Jacob V.$0http://id.loc.gov/authorities/names/n88675618
852 00 $boff,hsl$hRJ560$i.P34 2005 Q